TECHNOLOGY FOCUS - ORGANIC CHEMISTRY - Preparation (Claimed): Preparation of (I) comprises reacting substituted metal heterocyclic azide compounds of formula (A11) with alkylene compounds of formula (nasterisk(r+s)CC-R4) (B11) to give substituted metal heterocyclyl triazole compounds of formula (C11) (representative of (I)). Preferred Components: The organic functional material is a matrix material, preferably ketones, phosphinoxides, sulfoxides, sulfones, triarylamines, carbazoles, indolocarbazoles, indenocarbazoles, azacarbazoles, bipolar matrix materials, silanes, azaborolenes, boronesters, triazines, zinc complexes, diaza- or tetrazaziloles and/or diazaphospholes. Preferred Definitions:    s = 1;    M(L)n = e.g. substituted metal pyridinyl heterocyclyl moiety of formula (IX), substituted metal fused heterocyclyl moiety of formula (XI) or (XII), substituted metal pyridyl heterocyclyl moiety of formula (XXVII), substituted metal isoquinolinyl moiety of formula (XXIX) or (XXX);    X = CR1 or N;    Q = R1C=CR1, R1C=N, O, S, Se or NR1;    m = 0;    R5 = H; and    R4 = e.g. -CH3, -CH2-CH3, -CH(CH3)2, -C(CH3)3, -(CH2)7-CH3, -O-CH3, benzen-1-yl, 3,5-dimethyl-benzen-1-yl, 3,5-dicyano-benzen-1-yl, benzyl, naphthyl, anthracen-9-yl, biphenyl, 4-thiophene-benzen-1-yl, 4-(1-phenyl-1H-(1,2,3)triazol-4-yl)-phenyl, thiophen-2-yl, isothiazol-5-yl, benzofuran-2-yl, furan-2-yl, isoxazol-5-yl, quinolin-4-yl, 1H-tetrazol-1-yl, 5-fluoro-pyridin-2-benzen-4-yl, dibenzothiophenyl and thieno(3,2-b)thiophenyl.    ACTIVITY - Dermatological; Antipsoriatic; Keratolytic; Antiulcer; Antiseborrheic; Vulnerary; Hepatotropic; Antiinflammatory; Antiarthritic; Antirheumatic; Analgesic; Neuroprotective; Osteopathic; Cytostatic; Antiallergic; Virucide.    MECHANISM OF ACTION - None given.    EXAMPLE - 7.4 g Of copper iodide was added to a suspension of 11 g of tris(2-(3-azido-phenyl)-pyridinyl)iridium and 4.7 g of ethynyl-benzene in 300 ml of mixture of ethanol/water (7:3). The mixture was stirred for 24 hours. The obtained precipitate was filtered off, dissolved in dichloromethane, filtered over silica gel and washed three times with water. The organic phase was separated off, dried over magnesium sulfate, filtered and evaporated to dryness. The crude product was purified by recrystallization from a mixture of toluene/ethanol to give 11.1 g, 89% of tris(2-(3-(4-phenyl-(1,2,3)triazol-1-yl)-phenyl)-pyridinyl)iridium.